The new guidelines identify six different clinical groups of pulmonary hypertension, with a focus on treatment strategies and risk stratification. Pulmonary arterial hypertension (group 1) is the only group provided with specific drug therapy and an evidence-based treatment algorithm.
A new study reviews data from tens of thousands of patients to set forth suggested daily targets for omega-3 consumption. The study finds that omega-3 fatty acids can reduce the incidence of cardiac events and mortality in patients with existing heart disease, with a 30% reduction in CV-related death.
The American College of Cardiology advocates for a 'Quality First' approach to health care reform, focusing on increasing quality of care and ensuring patient access. The ACC has endorsed six principles necessary for effective reform, including universal coverage, focus on patient value, and payment reforms that reward quality.
The European Heart Rhythm Association's (EHRA) White Book reveals significant disparities in arrhythmia treatment across Europe. The book highlights differences in guideline implementation, trained physicians, and implantation rates, with some countries having no reimbursement for ICD or pacemaker therapy.
Researchers say that improved treatment selection and new therapies could help reduce mortality and rehospitalization rates in acute heart failure. Current treatments have not changed much despite the growing prevalence of heart failure, and the current guidelines emphasize urgent therapy.
The European Society of Cardiology's joint consensus document on catheter ablation for ventricular arrhythmias emphasizes the need for more clinical trials and registries to determine its long-term impact. Key unanswered questions include the efficacy, comparative success rates of drug and ablative therapies.
The SCAAR registry study analyzed 47,967 patients who received drug eluting stents (DES) between 2003 and 2006. The results found no significant difference in late mortality between DES and bare metal stent (BMS) groups.
A recent study by the National Heart, Lung, and Blood Institute found that patients at community health clinics are less likely to receive cardiology consultations than those at hospitals. Women and minority groups were also underrepresented among these consultations, highlighting disparities in heart care.
A new study published in the Journal of the American College of Cardiology: Cardiovascular Interventions found that organized STEMI networks consistently provide the fastest treatment of acute heart attacks, with 86% of patients receiving skilled coronary intervention within 90 minutes. This improvement surpasses the American College o...
Telemonitoring is being integrated into cardiac nursing practice to improve heart failure management. The technology enables nurses to remotely monitor patients' vital signs and provide guidance on lifestyle changes and medication.
The European Society of Cardiology reports that heart failure is the most prevalent chronic cardiac condition in Europe, with 30 million cases identified. Recent improvements in diagnosis and treatment have led to a significant reduction in mortality rates, but challenges persist in prevention, diagnosis, and treatment.
A study reveals nearly two-thirds of children receiving routine interventional cardiology procedures may be treated with off-label pediatric cardiac devices due to lack of regulatory oversight. The devices were used for approved purposes in 63% of patients, with stent implantations being 99% off-label.
Researchers found that patients with CAD who achieve very low LDL cholesterol levels (≤ 70 mg/dL) and normal systolic blood pressure (≤ 120 mmHg) experience the slowest progression of coronary disease. This study emphasizes the importance of aggressive control of all risk factors to prevent heart disease.
The study showed an overall 19% loss in luminal diameter at 18 months and an angiographic in-stent late loss of 0.48mm at two years, falling between bare metal and drug eluting stents. Patients did not appear to get any in-stent thrombosis.
Research suggests that depression can increase the risk of sudden cardiac death and fatal coronary heart disease in women. Women with more severe depressive symptoms or those who reported taking antidepressants were at higher risk for these events.
Research found that relatively healthy women with severe depression are at increased risk of cardiac events, including SCD and fatal CHD. Antidepressant use was strongly associated with this risk, particularly Sudden Cardiac Death.
The American Board of Medical Specialties approves a new subspecialty in Advanced Heart Failure and Transplant Cardiology, which will provide high-level care for patients with worsening heart failure. The first certified cardiologists will be trained by 2010, offering improved treatment options and outcomes for heart failure patients.
A French study found that healthy elderly people who report feeling sleepy during the day have a significantly higher risk of dying from cardiovascular disease. The Three City study found a 49% relative risk increase of cardiovascular death compared to those who do not report sleepiness.
The European Society of Cardiology has reaffirmed its advice on cardiovascular risks associated with long-haul flights. Studies suggest that flight duration exceeding four hours increases the risk of venous thromboembolism (VTE) due to immobility, dehydration, and reduced oxygen in the cabin.
A study published by the American College of Cardiology found that changes brought on by anger can predict future arrhythmias in patients with ICDs. Patients who experienced higher levels of anger-induced TWA were more likely to have arrhythmias requiring ICD termination.
The SYNTAX study found that CABG is associated with lower rates of repeat revascularization and stroke compared to PCI. Patients with high SYNTAX scores had significantly higher rates of major adverse cardiac events when treated with PCI.
The number of female cardiologists has nearly doubled over the past decade, yet women still account for less than 20% of all cardiologists. Women face significant challenges, including work-life balance, radiation exposure concerns, and personal roadblocks to career advancement.
The European Society of Cardiology recommends echocardiography as the first-line test for patients suspected of cardiovascular disease. Echocardiography provides accurate images of the heart's chambers, valves, and coronary arteries, allowing for diagnosis and prognosis without invasive procedures.
A growing body of evidence links low vitamin D levels to common CVD risk factors such as hypertension, obesity and diabetes. Researchers recommend screening and treating vitamin D deficiency in patients with risk factors for heart disease or diabetes.
The new clinical performance measures provide up-to-date tools for gauging how closely doctors are sticking to guideline recommendations. Key areas include statin prescription, PCI timeliness, referral to cardiac rehabilitation programs, and elimination of beta blocker treatment within 24 hours.
The guidelines provide clinical features, diagnosis, and treatment information for a range of congenital heart defects. They also highlight key issues to look for during follow-up and make recommendations on genetic testing, pregnancy, contraception, and physical activity.
A 12-week isoflavone supplement improved brachial artery dilation and reversed endothelial dysfunction in stroke patients. Isoflavone treatment also decreased high-sensitivity C-reactive protein levels, suggesting reduced vascular inflammatory stress.
A study by Henry Ford Health found that 90% of patients who underwent cardiac nuclear stress testing did so appropriately under updated guidelines. However, 21 patients received unnecessary tests, highlighting the potential for savings through adherence to test-appropriateness criteria.
The European Society of Cardiology has released updated guidelines for ST elevation infarction, emphasizing the importance of hospital networks and efficient ambulance services. The guidelines also provide recommendations for selecting primary PCI versus fibrinolytic therapy and incorporating antithrombotic co-therapies.
The Phase II clinical trial of FX06 showed a statistically significant reduction in myocardial necrosis following intravenous application concurrent with reperfusion. The peptide preserves blood vessel function by binding to VE-cadherin, leading to reduced inflammation and infarct sizes.
The APPRAISE-I trial found a non-statistically significant trend that patients taking apixaban with aspirin or clopidogrel had lower incidence of heart attack, stroke, and cardiovascular death, compared to those taking a placebo. However, bleeding complications were a concern, especially at higher doses.
The field of non-invasive cardiac imaging has evolved significantly, with various techniques such as echocardiography, cardiovascular magnetic resonance, and computed tomography available. However, clinicians face challenges in choosing the most suitable modality due to a plethora of options.
Recent studies on DES have shown mixed results, with some suggesting increased risk of late thrombosis but no impact on mortality or myocardial infarction. However, other data indicate benefits in terms of reduced reinterventions and improved outcomes for high-risk patients.
A randomized controlled trial found that omega-3 polyunsaturated fatty acids (PUFA) reduced mortality and hospital admission for cardiovascular reasons in patients with chronic heart failure. The study involved 357 Italian cardiology sites, with 3494 patients receiving PUFA supplements and 3481 receiving placebo.
The EUROACTION study found that a nurse-coordinated multidisciplinary family-based cardiology programme improved cardiovascular disease risk factors for patients with coronary heart disease and those at high risk. The programme also showed significant increases in physical activity levels, dietary improvements, and blood pressure contr...
Research suggests that high-flavanol cocoa can improve blood vessel function in people with type 2 diabetes, rivaling the benefits of exercise and common medications. Flavanols may help increase nitric oxide production, reducing artery stress and promoting cardiovascular health.
Cardiology researchers at The Children's Hospital of Philadelphia have developed a synthetic material that can bind to various gene therapy vectors, allowing controlled local release of therapeutic genes. In an animal study, the new formulation showed significant reduction in restenosis, a hazardous narrowing of blood vessels.
The Cedars-Sinai Heart Institute will feature presentations on various topics related to cardiovascular health, including emerging technologies for heart valve repair and women's heart issues. Researchers will also discuss the link between prohormones and cardiovascular disease risk among post-menopausal women.
A recent study published in the Journal of Nuclear Cardiology found significant differences in diagnostic performance among commercial software packages used for cardiac SPECT imaging. The collaborative research project aims to standardize cardiac-image analyses, enhancing medical outcomes and technology effectiveness.
A recent study found that patients taking statins were 61% less likely to develop atrial fibrillation. The American College of Cardiology also releases new performance measures for monitoring AF care, which focus on stroke prevention through medication and regular monitoring.
A new technique for treating patients with myocardial infarction uses a thrombectomy procedure to remove blockages and improve blood flow. This approach has shown promise in reducing the risk of further obstructions and improving clinical outcomes.
New research published in the Journal of the American College of Cardiology reveals that longstanding anxiety markedly increases the risk of heart attack, even when other cardiovascular risk factors are taken into account. Anxiety is unique among psychological factors in predicting heart disease risk.
David R. Holmes Jr., a Mayo Clinic cardiologist, received the James B. Herrick Award for his pioneering contributions to interventional cardiology and advancements in coronary revascularization through balloon angioplasty and stenting. His work has significantly improved patient care and saved countless lives.
Women who overcome breast cancer are at a higher risk of developing cardiovascular disease due to therapies that damage the heart and blood vessels. Exercise is crucial in maintaining heart health during treatment, and early evaluation of cardiovascular risk factors can help prevent complications.
The SCAI has announced that its leaders are available for comment on numerous studies, trials, and data releases at the upcoming European Society for Cardiology Congress. These studies focus on interventional cardiology, percutaneous intervention, angioplasty, and stents.
Two studies examine triage guidelines for emergency heart patients and find that those who followed the guidelines had similar outcomes to those who did not. However, low-risk patients who were discharged after receiving standard treatment had a small risk of developing acute coronary syndrome in the long term.
The revised guidelines introduce changes to the initial diagnostic approach, recommending a non-invasive set of preliminary tests such as stress tests or echocardiograms. The new guidelines also emphasize the importance of more intense lipid and blood pressure control, as well as the use of anti-platelet therapy clopidogrel for at leas...
A new study published by the American College of Cardiology found an association between low cholesterol levels and increased cancer risk. The research suggests that patients with high doses of statins may be at a higher risk of developing certain types of cancer.
A new study found high levels of MPO to signal increased risk for heart disease nearly a decade before conventional risk factors set off alarms. Elevated MPO levels also indicate unstable plaque and may be used to detect vulnerable patients.
The study found that women treated at top-performing hospitals have a significantly lower risk-adjusted mortality rate for cardiovascular disease, with an average improvement of 8.7%. The greatest quality gaps were seen in heart failure and interventional cardiology procedures.
The new guidelines provide up-to-date information on best practices and practical recommendations for diagnosing, assessing, and treating arterial hypertension. The update is based on a thorough review of scientific data from large clinical trials and observational studies.
The symposium highlights pioneering percutaneous interventions for aortic valve replacement and mitral valve repair, with promising results. Catheter-based stem cell therapy also shows promise in regenerating scarred heart areas and halting enlargement of the heart.
Research shows that elderly patients (90+ years) who receive recommended treatments for acute coronary syndromes have better survival rates, but at a higher risk of bleeding complications. Guidelines must be balanced to balance survival benefits with increased bleeding risk.
Researchers present three studies highlighting advances in clinical cardiology, including a new drug-exercise combination that improves image quality and reduces side effects. The studies also explore the best medical and interventional treatment for patients with acute coronary syndromes.
A study by the American College of Cardiology found that torcetrapib increased good cholesterol levels but failed to slow plaque buildup in coronary arteries. The drug also raised blood pressure, leading researchers to question its efficacy as a treatment for cardiovascular disease.
A randomized controlled trial found that peri-procedural hydration treatment with sodium bicarbonate and sodium chloride show similar rates of protection against contrast-induced nephropathy. The study evaluated 353 patients undergoing cardiac procedures and found no significant differences in kidney function between the two groups.
Long-term safety of drug-eluting stents in off-label use shows low mortality rates, with cardiac mortality at 0.8%, but high risk of late stent thrombosis among non-responders to clopidogrel. The MATRIX Registry found that 34% of patients had diabetes and 33% a history of heart attack.
A recent study found that combining a platelet inhibitor with an embolic protection device improves renal function in patients undergoing renal artery stenting. The use of abciximab reduced the occurrence of platelet-rich thrombi, while Angioguard alone was not associated with improved outcomes.
Research on silent myocardial ischemia shows that anti-anginal therapy, combined with risk factor control, improves outcomes and preserves left ventricular function. Additionally, faster door-to-balloon time for STEMI patients leads to reduced healthcare costs, heart attack rates, and hospital stays.
The EXACT study found that community hospital physicians can provide exemplary outcomes for patients in need of carotid stenting with appropriate experience levels and device training. The use of embolic protection devices has been shown to reduce peri-procedural complications by 4.5% compared to the SECuRITY study.